Pretreatment SUV could aid head and neck cancer therapy

02/25/2010 | EurekAlert!

The maximum standardized uptake value measured from FDG PET images of primary tumor in head and neck squamous cell carcinoma patients prior to treatment is predictive of disease-specific survival, overall survival and disease-free survival, a study said. The study also linked pretreatment SUVmax for lymphodenopathy to distant metastasis. "The findings of this study show that we may use SUV before treatment to personalize treatment approaches for some head and neck cancer patients since SUV has been shown to be associated with treatment outcomes," the study's lead author said.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX